daclizumab high yield process (BIIB019)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for daclizumab high yield process (BIIB019), covering 2018-11-09 to 2018-11-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis [Phase 2]